KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$15.53.

  • Gsk's Times Interest Earned fell 118158.92% to -$15.53 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.49, marking a year-over-year decrease of 4503.37%. This contributed to the annual value of $6.01 for FY2024, which is 2942.5% down from last year.
  • According to the latest figures from Q3 2025, Gsk's Times Interest Earned is -$15.53, which was down 118158.92% from -$10.99 recorded in Q2 2025.
  • Over the past 5 years, Gsk's Times Interest Earned peaked at -$1.21 during Q3 2024, and registered a low of -$23.18 during Q4 2021.
  • In the last 5 years, Gsk's Times Interest Earned had a median value of -$8.98 in 2024 and averaged -$9.04.
  • In the last 5 years, Gsk's Times Interest Earned skyrocketed by 8868.65% in 2024 and then crashed by 118158.92% in 2025.
  • Gsk's Times Interest Earned (Quarter) stood at -$23.18 in 2021, then soared by 83.44% to -$3.84 in 2022, then tumbled by 38.91% to -$5.33 in 2023, then grew by 12.09% to -$4.69 in 2024, then tumbled by 231.23% to -$15.53 in 2025.
  • Its Times Interest Earned was -$15.53 in Q3 2025, compared to -$10.99 in Q2 2025 and -$13.68 in Q1 2025.